Skip to main content
NBPSector not reported

NovaBridge Biosciences (NBP) Insider Trading

In the last 90 days, 3 NovaBridge Biosciences (NBP) insiders reported no open-market purchases and 3 sales totaling $88,325. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 18, 2026Phillip Andrew DennisChief Medical OfficerSale8,209$0.71$5,828
Sep 9, 2026Sean Wuxiong CaoChief Bus. Development OfficerSale107,978$0.74$79,904
Aug 31, 2026Cong Claire XuEVP, Clinical DevelopmentSale3,282$0.79$2,593
Jul 6, 2026Cong Claire XuSVP, Clinical DevelopmentSale4,485$0.89$3,992
Jun 18, 2026Phillip Andrew DennisChief Medical OfficerSale8,494$0.66$5,606
Jun 1, 2026Cong Claire XuSVP, Clinical DevelopmentSale3,494$3.94$13,766
May 14, 2026Sean Wuxiong CaoSee RemarksSale21,399$1.99$42,584
Apr 24, 2026Mark Arnold HaglerSee RemarksOpen Market Purchase230,000$2.51$577,300

Common questions

NBP insider trading FAQ

Are NBP insiders buying or selling?
Over the last 90 days, NBP insiders were net sellers, reporting $0.00 of open-market purchases and $88,325 of sales.
When was the last NBP insider purchase?
No open-market insider purchase of NovaBridge Biosciences stock was reported in the last 90 days.
Where does NBP insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that NovaBridge Biosciences officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.